ATC code N04

ATC codes
N Nervous system
N01 Anesthetics
N02 Analgesics
N03 Antiepileptics
N04 Anti-parkinson drugs
N05 Psycholeptics
N06 Psychoanaleptics
N07 Other nervous system drugs
ATCvet only
QN51 Products for animal euthanasia
A B C D G H QI J L M N P R S V (Hover over links to see titles)

ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

</ref> Subgroup N04 is part of the anatomical group N Nervous system.<ref>

ATC/DDD Index 2022

code N04(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN04.<ref>

ATCvet Index 2022

code QN04(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

N04A Anticholinergic agents

N04AA Tertiary amines

N04AA01 Trihexyphenidyl

N04AA02 Biperiden

N04AA03 Metixene

N04AA04 Procyclidine

N04AA05 Profenamine

N04AA08 Dexetimide

N04AA09 Phenglutarimide

N04AA10 Mazaticol

N04AA11 Bornaprine

N04AA12 Tropatepine

N04AB Ethers chemically close to antihistamines

N04AB01 Etanautine

N04AB02 Orphenadrine (chloride)

N04AC Ethers of tropine or tropine derivatives

N04AC01 Benzatropine

N04AC30 Etybenzatropine

N04B Dopaminergic agents

N04BA Dopa and dopa derivatives

N04BA01 Levodopa

N04BA02 Levodopa and decarboxylase inhibitor

N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor

N04BA04 Melevodopa

N04BA05 Melevodopa and decarboxylase inhibitor

N04BA06 Etilevodopa and decarboxylase inhibitor

N04BB Adamantane derivatives

N04BB01 Amantadine

N04BC Dopamine agonists

N04BC01 Bromocriptine

N04BC02 Pergolide

N04BC03 Dihydroergocryptine mesylate

N04BC04 Ropinirole

N04BC05 Pramipexole

N04BC06 Cabergoline

N04BC07 Apomorphine

N04BC08 Piribedil

N04BC09 Rotigotine

N04BD Monoamine oxidase B inhibitors

N04BD01 Selegiline

N04BD02 Rasagiline

N04BD03 Safinamide

N04BX Other dopaminergic agents

N04BX01 Tolcapone

N04BX02 Entacapone

N04BX03 Budipine

N04BX04 Opicapone